Interferon treatment for chronic hepatitis C virus infection in uremic patients.
作者： Paul Koenig , Wolfgang Vogel , Florian Umlauft , Katharina Weyrer , Rupert Prommegger
DOI: 10.1038/KI.1994.197
关键词:
摘要: Hepatitis C virus infection has been identified as the major cause of parenterally transmitted hepatitis [1]. Chronic is a problem in patients on maintenance hemodialysis awaiting kidney transplantation [21. Whereas uremia seems to predispose chronic viral carrier status with little inflammatory activity liver, change immune after modified by immunosuppressive drugs causes acceleration liver disease often leading death from failure [3]. For first time an effective therapy became available advent interferon treatment for infection. A bulk evidence accumulated during last decade showing that this benefit nonuremic [4, 5]. However, information presented so far chronically virus-infected uremic treated interferon. Therefore, we conducted study dialysis regard its efficacy suppressing viremia and tolerability side effects. We report result open multicenter trial suffering The was Austrian Association Nephrology.
core.ac.uk
kidney-international.org
nature.com
sci-hub.se 参考文章(12)
Fabio Tine', Silvio Magrin, Antonio Craxi', Luigi Pagliaro, Interferon for non-A, non-B chronic hepatitis Journal of Hepatology. ,vol. 13, pp. 192- 199 ,(1991) , 10.1016/0168-8278(91)90814-R
Peter Kurz, Hans Köhler, Stephan Meuer, Thomas Hütteroth, Karl–Hermann Meyer zum Büschenfelde, Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney International. ,vol. 29, pp. 1209- 1214 ,(1986) , 10.1038/KI.1986.129
Michiko Shindo, Adrian M. di Bisceglie, Jay H. Hoofnagle, Long‐term follow‐up of patients with chronic hepatitis C treated with α‐interferon Hepatology. ,vol. 15, pp. 1013- 1016 ,(1992) , 10.1002/HEP.1840150607
Tak Mao Chan, Anna Suk Fong Lok, Ignatius Kum Po Cheng, Rachel Tzun Chan, None, Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays Hepatology. ,vol. 17, pp. 5- 8 ,(1993) , 10.1002/HEP.1840170103
S. Kwok, R. Higuchi, Avoiding false positives with PCR Nature. ,vol. 339, pp. 237- 238 ,(1989) , 10.1038/339237A0
L. P. RYDER, A. SVEJGAARD, E. LANGHOFF, B. HOFMANN, N. ODUM, J. LADEFOGED, P. PLATZ, Kinetic analysis of interleukin 2 (IL-2) production and expression of IL-2 receptors by uraemic and normal lymphocytes. Scandinavian Journal of Immunology. ,vol. 25, pp. 29- 36 ,(1987) , 10.1111/J.1365-3083.1987.TB01043.X
P P Ulrich, J M Romeo, L J Daniel, G N Vyas, An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. Genome Research. ,vol. 2, pp. 241- 249 ,(1993) , 10.1101/GR.2.3.241
Hideki Hagiwara, Norio Hayashi, Eiji Mita, Keiji Ueda, Tetsuo Takehara, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α Hepatology. ,vol. 15, pp. 37- 41 ,(1992) , 10.1002/HEP.1840150108
Piotr Chomczynski, Nicoletta Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Analytical Biochemistry. ,vol. 162, pp. 156- 159 ,(1987) , 10.1016/0003-2697(87)90021-2
Gary L. Davis, Luis A. Balart, Eugene R. Schiff, Karen Lindsay, Henry C. Bodenheimer, Robert P. Perrillo, William Carey, Ira M. Jacobson, John Payne, Jules L. Dienstag, David H. VanThiel, Carlo Tamburro, Jay Lefkowitch, Janice Albrecht, Carlton Meschievitz, Terryl J. Ortego, Alexandra Gibas, , Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. The New England Journal of Medicine. ,vol. 321, pp. 1501- 1506 ,(1989) , 10.1056/NEJM198911303212203